About Epsilon-Biotech
Epsilon-Biotech is a private limited company (BV/SRL) based in Zonhoven, founded in 1994. Its main activity is classified as "Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied". For the 2025 financial year, Epsilon-Biotech reported a profit of €17,279. That makes 5 profitable financial years in a row for Epsilon-Biotech. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €42,143, down 44% on 2024. Equity stands at €220,466, a solvency ratio of 90%. In 2006 it was €146,365. 19 annual accounts are available, covering 2006 to 2025.
- Signals
-
ProfitableProfitable € 25K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 220KStrong equity provides a buffer against setbacks.
Low riskLow risk 90.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 8.53A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 30KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 38KPositive EBITDA: operating activities are profitable.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
42K
|
€
75K
|
€
65K
|
€
36K
|
|
|
€
38K
|
€
72K
|
€
58K
|
€
35K
|
|
|
€
17K
|
€
47K
|
€
52K
|
€
30K
|
|
|
€
220K
|
€
203K
|
€
157K
|
€
105K
|
|
|
90.07%
|
88.35%
|
82.73%
|
58.09%
|
|
|
€
24K
|
€
27K
|
€
33K
|
€
76K
|
|
|
€
193K
|
€
156K
|
€
69K
|
€
76K
|
Publications 22
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Doel - Ontslagen - Benoemingen - Algemene Vergadering - Boekjaar 13/11/2020
- Me. - Jaarrekening 31.12.2015, Ggk 01.05.2016, Ngl 01.06.2016 16147-0254-017 08/06/2016
- Me. - Jaarrekening 31.12.2014, Ggk 01.05.2015, Ngl 20.05.2015 15126-0255-017 27/05/2015
- Me. - Jaarrekening 31.12.2013, Ggk 01.05.2014, Ngl 27.06.2014 14220-0165-016 02/07/2014
- Kapitaal - Aandelen 08/05/2014
Frequently asked questions
Answers to the most common questions about Epsilon-Biotech, based on official government data and the filed annual accounts.
What is the VAT number of Epsilon-Biotech?
The VAT number of Epsilon-Biotech is BE0453.963.661.
When was Epsilon-Biotech established?
Epsilon-Biotech was founded in 06-12-1994.
What is the official address of Epsilon-Biotech?
The official address of Epsilon-Biotech is Beverzakbroekweg 91 Zonhoven 3520.
What is the legal form of Epsilon-Biotech?
The juridical form of Epsilon-Biotech is Private limited company (BV/SRL).
What is the annual revenue of Epsilon-Biotech?
The 2025 accounts of Epsilon-Biotech do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Epsilon-Biotech a reliable company?
Epsilon-Biotech is a registered Rechtspersoon with company number 0453.963.661 and can be verified through the official CBE database.
What is the credit limit of Epsilon-Biotech?
The estimated credit limit of Epsilon-Biotech is €47,967.
Is Epsilon-Biotech still active?
Epsilon-Biotech currently has the status "Normal situation" and is active.